Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type I and II Interferons in the Anti-Tumor Immune Response
Sarah E. Fenton, Diana Saleiro, Leonidas C. Platanias
Cancers (2021) Vol. 13, Iss. 5, pp. 1037-1037
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy
Roni Shouval, Ana Alarcón Tomás, Joshua Fein, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 4, pp. 369-381
Open Access | Times Cited: 97
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
Yurong Qin, Miaozhe Huo, Xingwu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Host Cell Death and Modulation of Immune Response against Mycobacterium tuberculosis Infection
Annie Vu, Ira Glassman, Giliene Campbell, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6255-6255
Open Access | Times Cited: 10
Physiological functions of ULK1/2
Gautam Pareek, Mondira Kundu
Journal of Molecular Biology (2024) Vol. 436, Iss. 15, pp. 168472-168472
Open Access | Times Cited: 8
HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System
Anna M. Cyran, Anatoly Zhitkovich
Chemical Research in Toxicology (2022) Vol. 35, Iss. 10, pp. 1690-1700
Open Access | Times Cited: 29
Targeting STING in cancer: Challenges and emerging opportunities
Kexin Zhao, Jiaojiao Huang, Yue Zhao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188983-188983
Closed Access | Times Cited: 20
hnRNPM protects against the dsRNA-mediated interferon response by repressing LINE-associated cryptic splicing
Rong Zheng, Mikayla Dunlap, Georg O.M. Bobkov, et al.
Molecular Cell (2024) Vol. 84, Iss. 11, pp. 2087-2103.e8
Closed Access | Times Cited: 7
Physical Activity Decreases Inflammation and Delays Development of Obesity-Associated Pancreatic Ductal Adenocarcinoma
Valentina Pita-Grisanti, Ericka Vélez-Bonet, Kaylin Chasser, et al.
Cancer Research (2024) Vol. 84, Iss. 18, pp. 3058-3071
Closed Access | Times Cited: 6
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer
Bilal Unal, Omer F. Kuzu, Yang Jin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy
Christine Moussion, Lélia Delamarre
Seminars in Immunology (2023) Vol. 71, pp. 101848-101848
Closed Access | Times Cited: 15
Temozolomide monotherapy versus combination therapies in melanoma: a meta-analysis of efficacy and safety
Lu Chen, Beichen Cai, Xuejun Ni, et al.
Melanoma Research (2025)
Closed Access
Intralesional injection of CpG ODNs complexed with glatiramer acetate mitigates systemic cytokine toxicities and synergistically advances checkpoint blockade efficacy
Huan Gong, J. Daniel Griffin, Chad E. Groer, et al.
Drug Delivery and Translational Research (2025)
Closed Access
In Situ Tumor Vaccination Using Lipid Nanoparticles to Deliver Interferon-β mRNA Cargo
Kenji Kimura, Aidan Aicher, Emma Niemeyer, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 178-178
Open Access
Interferon-driven Metabolic Reprogramming and Tumor Microenvironment Remodeling
Tzu-Hsuan Chang, Ping‐Chih Ho
Immune Network (2025) Vol. 25, Iss. 1
Open Access
The role of type I interferon signaling in myeloid anti-tumor immunity
Sofie Patrizia Meyer, Rebekka Bauer, Bernhard Brüne, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models
Alessandro Sammarco, Giorgia Guerra, Katharina M. Eyme, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Innate Immune Memory in Macrophages
Akhil Maheshwari
Newborn (2023) Vol. 2, Iss. 1, pp. 60-79
Open Access | Times Cited: 12
Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
Apsana Lamsal, Sonja Andersen, Ida Johansson, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Dissection of Tumoral Niches Using Spatial Transcriptomics and Deep Learning
Karla Paniagua, Yufang Jin, Yidong Chen, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112214-112214
Open Access
A targeted MAVS fusion protein for controlled innate immune activation and antitumor therapy
Muhan Wang, Zhijie Zhang, Yanwei Yang, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Delivery of Interferon β-Encoding Plasmid via Lipid Nanoparticle Restores Interferon β Expression to Enhance Antitumor Immunity in Colon Cancer
Yingcui Yang, Shixuan Bo, Liyan Liang, et al.
ACS Nano (2024)
Closed Access | Times Cited: 3
Microtubule disruption synergizes with STING signaling to show potent and broad-spectrum antiviral activity
Jing Han, Zhimeng Wang, Fangping Han, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 2, pp. e1012048-e1012048
Open Access | Times Cited: 3
NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy
Awais Ali, Abdulaziz Alamri, Azraida Hajar
Immunologic Research (2024)
Closed Access | Times Cited: 3
Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma
Fan Cui, Jichang Wu, Yilin Shen, et al.
Cancer Medicine (2021) Vol. 11, Iss. 4, pp. 922-930
Open Access | Times Cited: 20
The rise of viperin: the emerging role of viperin in cancer progression
Alyssa G. Weinstein, Inês Godet, Daniele M. Gilkes
Journal of Clinical Investigation (2022) Vol. 132, Iss. 24
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top